XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Fair Value Measurements | 9 Months Ended
--- | ---
Sep. 30, 2017
Fair Value Disclosures [Abstract] |
Fair Value Measurements | 13. Fair Value Measurements Recurring Fair Value Measurements. The following table presents information about our financial instruments measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 using the inputs and fair value hierarchy discussed in Note 2, "Summary of Significant Accounting Policies and Recent Accounting Pronouncements": Financial Instruments Measured at Fair Value on a Recurring Basis
| September 30, 2017 |  | December 31, 2016
(in millions) | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total
Other Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred compensation plan investments (1) | $ | 116.2 |  |  | $ | — |  |  | $ | — |  |  | $ | 116.2 |  |  | $ | 80.6 |  |  | $ | — |  |  | $ | — |  |  | $ | 80.6 |
Derivative financial instruments - forward interest rate swap | — |  |  | 1.8 |  |  | — |  |  | 1.8 |  |  | — |  |  | — |  |  | — |  |  | — |
(1) | Approximately $3.0 million and $8.3 million of participant cash was withdrawn from our deferred compensation plan investments during the nine months ended September 30, 2017 and the year ended December 31, 2016, respectively. Approximately $23.2 million and $25.4 million of shares in the compensation plan were diversified into the deferred compensation plan investments during the nine months ended September 30, 2017 and the year ended December 31, 2016, respectively.
Non-Recurring Fair Value Disclosures. There were no events during the three or nine month periods ended September 30, 2017 or 2016 which required fair value adjustments of our non-financial assets and non-financial liabilities. Financial Instrument Fair Value Disclosures. The following table presents the carrying and estimated fair values of our notes payable at September 30, 2017 and December 31, 2016, in accordance with the policies discussed in Note 2, "Summary of Significant Accounting Policies and Recent Accounting Pronouncements."
| September 30, 2017 |  | December 31, 2016
(in millions) | Carrying Value |  | Estimated Fair Value |  | Carrying Value |  | Estimated Fair Value
Fixed rate notes payable | $ | 2,029.2 |  |  | $ | 2,112.0 |  |  | $ | 2,274.9 |  |  | $ | 2,347.0 |
Floating rate notes payable | 175.0 |  |  | 173.2 |  |  | 205.7 |  |  | 200.5 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration